Document Classification

Section Type: RESULTS

Text: The IOP reduction was greater in both study groups compared with the previous combination therapy with timolol and another nonprostaglandin medication in millimeters of mercury (7. 7 + / -2. 3 vs. 5. 5 + / -2. 3, P < 0. 001, for the latanoprost group ; 8. 5 + / -3. 5 vs. 6. 3 + / -2. 7, P < 0. 001, for the latanoprost-timolol group) and percentage (35. 8 + / -8. 2 % vs. 25. 6 + / -8. 9 %, P < 0. 001, for the latanoprost group ; 38. 6 + / -8. 7 % vs. 28. 6 + / -9. 0 %, P < 0. 001, for the latanoprost-timolol group).